|
|
Volumn 40, Issue 3 Suppl, 2004, Pages 19-22
|
|
FDA regulation of allogeneic islets as a biological product.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL PRODUCT;
CYCLIC GMP;
ARTICLE;
BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM;
BIOLOGICAL THERAPY;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
METABOLISM;
METHODOLOGY;
PANCREAS ISLET;
PANCREAS ISLET TRANSPLANTATION;
PATHOLOGY;
UNITED STATES;
BIOLOGICAL PROCESSES;
BIOLOGICAL PRODUCTS;
CYCLIC GMP;
DIABETES MELLITUS, TYPE 1;
DRUG APPROVAL;
HUMANS;
INVESTIGATIONAL NEW DRUG APPLICATION;
ISLETS OF LANGERHANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
TISSUE THERAPY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
|
EID: 24644470634
PISSN: None
EISSN: 15590283
Source Type: Journal
DOI: 10.1385/cbb:40:3:19 Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
